Efficacy and Safety of Eptinezumab in Patients With Chronic Migraine: PROMISE-2
- PMID: 37015824
- PMCID: PMC10574813
- DOI: 10.1212/WNL.0000000000207168
Efficacy and Safety of Eptinezumab in Patients With Chronic Migraine: PROMISE-2
Erratum for
-
Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2.Neurology. 2020 Mar 31;94(13):e1365-e1377. doi: 10.1212/WNL.0000000000009169. Epub 2020 Mar 24. Neurology. 2020. PMID: 32209650 Free PMC article. Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources